Investors Face September 22 Deadline in PROCEPT BioRobotics Lawsuit

The lawsuit alleges that PROCEPT artificially inflated its financial performance through an aggressive, undisclosed discount program. This initiative reportedly incentivized customers to place bulk orders far exceeding actual procedure demand, effectively pulling future revenue into earlier reporting periods. By the end of the class period, the firm claims this strategy resulted in a massive inventory glut, with more than 10,000 excess handpiece units sitting in the field.

According to the complaint, these practices left PROCEPT unable to meet its 2025 financial guidance, which investigators argue lacked a factual basis from the start. Investors who incurred losses exceeding $100,000 are being encouraged to seek lead plaintiff status to help direct the litigation. Those wishing to participate must move the court by September 22, 2026. While the lawsuit has been filed, no class has been certified, meaning shareholders currently remain unrepresented unless they retain private counsel or choose to remain as absent class members.